A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia

Trial Profile

A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia

Recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Aug 2017

At a glance

  • Drugs Vosoritide (Primary)
  • Indications Achondroplasia
  • Focus Therapeutic Use
  • Sponsors BioMarin Pharmaceutical
  • Most Recent Events

    • 13 Jun 2017 Planned number of patients changed from 200 to 250.
    • 13 Jun 2017 Planned End Date changed from 1 Nov 2017 to 1 Feb 2025.
    • 13 Jun 2017 Planned primary completion date changed from 1 May 2017 to 1 Oct 2024.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top